Which company invested in KOEDA Co., Ltd. to support its medical innovation?

MUFG Capital invested in KOEDA Co., Ltd. to support its development of innovative medical devices.

In which countries does KOEDA plan to conduct clinical trials for its new anchors?

KOEDA plans to conduct clinical trials and expand in Japan, the United States, and Spain.

What specific digestive conditions is KOEDA targeting with its next-generation anchor technology?

KOEDA is targeting acute cholecystitis and gastrojejunal bypass with its next-generation anchor devices.

How will MUFG Capital’s network support KOEDA Co., Ltd. after the investment?

MUFG Capital’s network will support KOEDA’s clinical trials and international expansion efforts.

AI News NQ Analysis

MUFG Capital Invests in KOEDA Co., Ltd., Developing Next-Generation Anchors for Innovative Digestive Disease Treatment

NQ Score 89/100

N1 Content Completeness 90

AI Summary (NQ-processed)

MUFG Capital has invested in KOEDA Co., Ltd., a medical device startup developing next-generation anchors for endoscopic treatment of digestive diseases. KOEDA aims to innovate treatments for acute cholecystitis and gastrojejunal bypass, planning clinical trials and expansion in Japan, the US, and Spain, supported by MUFG's network.

AI Analysis

Frequently Asked Questions

Q: What medical device is KOEDA Co., Ltd. developing for digestive disease treatment?: A: KOEDA Co., Ltd. is developing next-generation anchors for endoscopic treatment of digestive diseases.
Q: Which company invested in KOEDA Co., Ltd. to support its medical innovation?: A: MUFG Capital invested in KOEDA Co., Ltd. to support its development of innovative medical devices.
Q: In which countries does KOEDA plan to conduct clinical trials for its new anchors?: A: KOEDA plans to conduct clinical trials and expand in Japan, the United States, and Spain.
Q: What specific digestive conditions is KOEDA targeting with its next-generation anchor technology?: A: KOEDA is targeting acute cholecystitis and gastrojejunal bypass with its next-generation anchor devices.
Q: How will MUFG Capital’s network support KOEDA Co., Ltd. after the investment?: A: MUFG Capital’s network will support KOEDA’s clinical trials and international expansion efforts.